Home › Trial NCT01884168
Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy
- Trial IDNCT01884168
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorCapital Medical University
- Enrollment30
- Start date2013-03
- ConditionsMalignant Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.